Michael W Bonney - Net Worth and Insider Trading

Over the past 18 months, Michael W Bonney made no insider transaction in Bristol-Myers Squibb Co (BMY). Other recent insider transactions involving Bristol-Myers Squibb Co (BMY) include a net sale of 45,419 shares made by Ann Powell Judge , a net sale of 96,295 shares made by Rupert Vessey , and a net purchase of 5,071 shares made by Christopher S. Boerner .

In summary, during the past 3 months, insiders sold 0 shares of Bristol-Myers Squibb Co (BMY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 382,446 shares of Bristol-Myers Squibb Co (BMY) were sold and 13,571 shares were bought by its insiders, resulting in a net sale of 368,875 shares.

Bristol-Myers Squibb Co (BMY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael W Bonney made 2 insider transaction in Alnylam Pharmaceuticals Inc (ALNY) with a net sale of 36,448. Other recent insider transactions involving Alnylam Pharmaceuticals Inc (ALNY) include a net sale of 30,567 shares made by Pushkal Garg , a net sale of 7,095 shares made by Indrani Lall Franchini , and a net sale of 14,604 shares made by Yvonne Greenstreet .

In summary, during the past 3 months, insiders sold 36,501 shares of Alnylam Pharmaceuticals Inc (ALNY) in total and bought 0 shares, with a net sale of 36,501 shares. During the past 18 months, 159,676 shares of Alnylam Pharmaceuticals Inc (ALNY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 159,676 shares.

Alnylam Pharmaceuticals Inc (ALNY)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Kaleido Biosciences Inc (KLDO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kaleido Biosciences Inc (KLDO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Kaleido Biosciences Inc (KLDO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael W Bonney made no insider transaction in Magenta Therapeutics Inc (MGTA). Other recent insider transactions involving Magenta Therapeutics Inc (MGTA) include a net sale of 3,700,000 shares made by Third Rock Ventures Iv, L.p. ,

In summary, during the past 3 months, insiders sold 0 shares of Magenta Therapeutics Inc (MGTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,700,000 shares of Magenta Therapeutics Inc (MGTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,700,000 shares.

Magenta Therapeutics Inc (MGTA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael W Bonney made no insider transaction in Sarepta Therapeutics Inc (SRPT). Other recent insider transactions involving Sarepta Therapeutics Inc (SRPT) include a net purchase of 68,532 shares made by Michael Andrew Chambers , a net sale of 30,000 shares made by Wigzell Hans Lennart Rudolf , and a net sale of 3,993 shares made by Stephen Mayo .

In summary, during the past 3 months, insiders sold 24,096 shares of Sarepta Therapeutics Inc (SRPT) in total and bought 0 shares, with a net sale of 24,096 shares. During the past 18 months, 39,954 shares of Sarepta Therapeutics Inc (SRPT) were sold and 143,757 shares were bought by its insiders, resulting in a net purchase of 103,803 shares.

Sarepta Therapeutics Inc (SRPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael W Bonney made no insider transaction in Syros Pharmaceuticals Inc (SYRS). Other recent insider transactions involving Syros Pharmaceuticals Inc (SYRS) include a net sale of 30,523 shares made by David Roth , a net purchase of 904,977 shares made by Srinivas Akkaraju , and a net sale of 689 shares made by Eric R Olson .

In summary, during the past 3 months, insiders sold 10,601 shares of Syros Pharmaceuticals Inc (SYRS) in total and bought 0 shares, with a net sale of 10,601 shares. During the past 18 months, 31,212 shares of Syros Pharmaceuticals Inc (SYRS) were sold and 904,977 shares were bought by its insiders, resulting in a net purchase of 873,765 shares.

Syros Pharmaceuticals Inc (SYRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Global Blood Therapeutics Inc (GBT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Global Blood Therapeutics Inc (GBT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Global Blood Therapeutics Inc (GBT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael W Bonney made no insider transaction in Tekla World Healthcare Fund (THW). Other recent insider transactions involving Tekla World Healthcare Fund (THW) include a net purchase of 200 shares made by Kathleen Goetz ,

In summary, during the past 3 months, insiders sold 0 shares of Tekla World Healthcare Fund (THW) in total and bought 200 shares, with a net purchase of 200 shares. During the past 18 months, 0 shares of Tekla World Healthcare Fund (THW) were sold and 200 shares were bought by its insiders, resulting in a net purchase of 200 shares.

Tekla World Healthcare Fund (THW)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael W Bonney made no insider transaction in Tekla Healthcare Opportunities Fund (THQ). Other recent insider transactions involving Tekla Healthcare Opportunities Fund (THQ) include a net purchase of 1,000 shares made by Bill Maher , and a net purchase of 600 shares made by Kathleen Goetz .

In summary, during the past 3 months, insiders sold 0 shares of Tekla Healthcare Opportunities Fund (THQ) in total and bought 600 shares, with a net purchase of 600 shares. During the past 18 months, 0 shares of Tekla Healthcare Opportunities Fund (THQ) were sold and 1,600 shares were bought by its insiders, resulting in a net purchase of 1,600 shares.

Tekla Healthcare Opportunities Fund (THQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael W Bonney made no insider transaction in abrdn Healthcare Investors (HQH). Other recent insider transactions involving abrdn Healthcare Investors (HQH) include a net purchase of 19,000 shares made by Daniel R Omstead , a net purchase of 1,000 shares made by Bill Maher , and a net purchase of 1,000 shares made by Todd Reit .

In summary, during the past 3 months, insiders sold 0 shares of abrdn Healthcare Investors (HQH) in total and bought 525 shares, with a net purchase of 525 shares. During the past 18 months, 0 shares of abrdn Healthcare Investors (HQH) were sold and 21,695 shares were bought by its insiders, resulting in a net purchase of 21,695 shares.

abrdn Healthcare Investors (HQH)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael W Bonney made no insider transaction in abrdn Life Sciences Investors (HQL). Other recent insider transactions involving abrdn Life Sciences Investors (HQL) include a net purchase of 429,402 shares made by Saba Capital Management, L.p. , a net purchase of 22,096 shares made by Daniel R Omstead , and a net purchase of 1,000 shares made by Bill Maher .

In summary, during the past 3 months, insiders sold 0 shares of abrdn Life Sciences Investors (HQL) in total and bought 429,802 shares, with a net purchase of 429,802 shares. During the past 18 months, 0 shares of abrdn Life Sciences Investors (HQL) were sold and 453,898 shares were bought by its insiders, resulting in a net purchase of 453,898 shares.

abrdn Life Sciences Investors (HQL)'s detailed insider trading history can be found in Insider Trading Tracker table.